发明名称 METHODS AND SYSTEMS FOR PRESENTING A COMBINATION TREATMENT
摘要 Methods, computer program products, and systems are described that include accepting an indication of a schedule for administration of a bioactive agent to an individual and presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the bioactive agent to the individual.
申请公布号 US2016074583(A1) 申请公布日期 2016.03.17
申请号 US201514853726 申请日期 2015.09.14
申请人 Searete LLC 发明人 Hyde Roderick A.;Ishikawa Muriel Y.;Leuthardt Eric C.;Levien Royce A.;Lord Robert W.;Malamud Mark A.;Sweeney Elizabeth A.;Wood, JR. Lowell L.;Wood Victoria Y.H.
分类号 A61M5/172;G06F19/00;A61M21/02 主分类号 A61M5/172
代理机构 代理人
主权项 1. A system comprising: at least one administration unit including at least one bioactive agent and that is operable to deliver the at least one bioactive agent to an individual; and at least one mobile device that is communicably linked with the at least one administration unit and that is operable to monitor one or more aspects of the individual, the at least one mobile device including at least: one or more media including one or more executable instructions; andat least one processor operatively connected to the one or more media, wherein the at least one processor is configured to execute the one or more executable instructions to perform operations including at least: monitoring one or more aspects of the individual using the at least one mobile device;detecting at least one symptom associated with the individual based at least partly on one or more monitored aspects of the individual which deviate from one or more specified levels of normalcy;controlling dosage of the at least one bioactive agent administered to the individual using the at least one administration unit at least partly in response to detection of the at least one symptom associated with the individual; andimplementing at least one computer-based simulated interactive experience using the at least one mobile device at one or more times relative to administration of the at least one bioactive agent when concentration of the at last one bioactive agent is expected to be below at least one specified value determined based at least partly on one or more pharmacokinetic profiles of the at least one bioactive agent.
地址 Bellevue WA US